Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1034871.RAu3Fe2TFYllaiTkv2tkKV15UEQ-TpK-EQERcuWtQjIQY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1034871.RAu3Fe2TFYllaiTkv2tkKV15UEQ-TpK-EQERcuWtQjIQY130_assertion type Assertion NP1034871.RAu3Fe2TFYllaiTkv2tkKV15UEQ-TpK-EQERcuWtQjIQY130_head.
- NP1034871.RAu3Fe2TFYllaiTkv2tkKV15UEQ-TpK-EQERcuWtQjIQY130_assertion description "[Recognizing EGFR as key orchestrator of the metastatic process in colorectal cancer, but also the substantial heterogeneity of responses to anti-EGFR therapy, we examined the pattern of composite tumor kinase activities governed by EGFR-mediated signaling that might be implicated in development of metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1034871.RAu3Fe2TFYllaiTkv2tkKV15UEQ-TpK-EQERcuWtQjIQY130_provenance.
- NP1034871.RAu3Fe2TFYllaiTkv2tkKV15UEQ-TpK-EQERcuWtQjIQY130_assertion evidence source_evidence_literature NP1034871.RAu3Fe2TFYllaiTkv2tkKV15UEQ-TpK-EQERcuWtQjIQY130_provenance.
- NP1034871.RAu3Fe2TFYllaiTkv2tkKV15UEQ-TpK-EQERcuWtQjIQY130_assertion SIO_000772 23226389 NP1034871.RAu3Fe2TFYllaiTkv2tkKV15UEQ-TpK-EQERcuWtQjIQY130_provenance.
- NP1034871.RAu3Fe2TFYllaiTkv2tkKV15UEQ-TpK-EQERcuWtQjIQY130_assertion wasDerivedFrom befree-2016 NP1034871.RAu3Fe2TFYllaiTkv2tkKV15UEQ-TpK-EQERcuWtQjIQY130_provenance.
- NP1034871.RAu3Fe2TFYllaiTkv2tkKV15UEQ-TpK-EQERcuWtQjIQY130_assertion wasGeneratedBy ECO_0000203 NP1034871.RAu3Fe2TFYllaiTkv2tkKV15UEQ-TpK-EQERcuWtQjIQY130_provenance.